Roberto S. Accolla

About Roberto S. Accolla

Roberto S. Accolla, With an exceptional h-index of 50 and a recent h-index of 23 (since 2020), a distinguished researcher at Università degli Studi dell'Insubria, specializes in the field of Immunology, Virology, Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

The NLR member CIITA: master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine

Human T cell leukemia virus-1 (HTLV-1) infection, associated pathology and response of the host

Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly

Reply to the Letter to the Editor:“Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine” by Francavilla B et al …

Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells

OS08. 5. A Adenovirus-mediated delivery of the MHC-II Transactivator CIITA gene induces tumor cell killing in immunocompetent glioblastoma organoids

Roberto S. Accolla Information

University

Position

Professor of General Pathology and Immunology Italy

Citations(all)

9103

Citations(since 2020)

2138

Cited By

7760

hIndex(all)

50

hIndex(since 2020)

23

i10Index(all)

141

i10Index(since 2020)

47

Email

University Profile Page

Università degli Studi dell'Insubria

Google Scholar

View Google Scholar Profile

Roberto S. Accolla Skills & Research Interests

Immunology

Virology

Oncology

Top articles of Roberto S. Accolla

Title

Journal

Author(s)

Publication Date

Virology, pathogenesis, epidemiology and clinical management of HTLV-1 infection. Proceedings of the 30th HTLV European research network (HERN 2023)

NeuroImmune Pharmacology and Therapeutics

Carmen de Mendoza

Graham Taylor

Antoine Gessain

Andrea K Thoma-Kress

Charles Bangham

...

2024/1/11

The NLR member CIITA: master controller of adaptive and intrinsic immunity and unexpected tool in cancer immunotherapy

Greta Forlani

Mariam Shallak

Andrea Gatta

Amruth KB Shaik

Roberto S Accolla

2023/7/17

Mucosal immune response after the booster dose of the BNT162b2 COVID-19 vaccine

EBioMedicine

Lorenzo Azzi

Daniela Dalla Gasperina

Giovanni Veronesi

Mariam Shallak

Vittorio Maurino

...

2023/2/1

Human T cell leukemia virus-1 (HTLV-1) infection, associated pathology and response of the host

Roberto S Accolla

Steven Jacobson

Luc Willems

Toshiki Watanabe

2023/6/30

Humoral and Cellular Immune Response Elicited by the BNT162b2 COVID-19 Vaccine Booster in Elderly

International Journal of Molecular Sciences

Daniela Dalla Gasperina

Giovanni Veronesi

Carlo M Castelletti

Stefania Varchetta

Sabrina Ottolini

...

2023/9/6

Reply to the Letter to the Editor:“Importance of nasal secretions in the evaluation of mucosal immunity elicited by mRNA BNT162b2 COVID-19 vaccine” by Francavilla B et al …

EBioMedicine

Lorenzo Azzi

Daniela Dalla Gasperina

Roberto Sergio Accolla

Greta Forlani

2022/5/1

Tumor recognition and acquisition of protecting adaptive anti-tumor immune response in vivo against CIITA-driven MHC class II expressing Oral Squamous Cell Carcinoma Cells

F Celesti

L Azzi

M Shallak

A Gatta

Rs Accolla

...

2022

OS08. 5. A Adenovirus-mediated delivery of the MHC-II Transactivator CIITA gene induces tumor cell killing in immunocompetent glioblastoma organoids

Neuro-Oncology

I Salvato

E Klein

G Forlani

A Poli

A Oudin

...

2022/9

Intracranic injection of CIITA-driven MHC-II positive glioblastoma cells induces an effective anti-tumor immune response in vivo: implication for new therapeutic strategies …

A Gatta

F Celesti

Am Chiaravalli

M Cerati

M Shallak

...

2022

The endogenous HBZ interactome in ATL leukemic cells reveals an unprecedented complexity of host interacting partners involved in RNA splicing

Frontiers in Immunology

Mariam Shallak

Tiziana Alberio

Mauro Fasano

Maria Monti

Ilaria Iacobucci

...

2022/8/1

Mucosal immune response in BNT162b2 COVID-19 vaccine recipients

EBioMedicine

Lorenzo Azzi

Daniela Dalla Gasperina

Giovanni Veronesi

Mariam Shallak

Giuseppe Ietto

...

2022/1/1

The Road to HTLV-1-Induced Leukemia by Following the Subcellular Localization of HTLV-1-Encoded HBZ Protein

Roberto S Accolla

2022/6/23

Phase I/II multicenter trial of a novel therapeutic cancer vaccine, HepaVac-101, for hepatocellular carcinoma

Clinical Cancer Research

Markus W Löffler

Stefania Gori

Francesco Izzo

Andrea Mayer-Mokler

Paolo A Ascierto

...

2022/6/13

HTLV-1 infection and pathogenesis: New insights from cellular and animal models

Greta Forlani

Mariam Shallak

Roberto Sergio Accolla

Maria Grazia Romanelli

2021/7/27

HTLV-1 Infection and Adult T Cell Leukemia Mechanisms of Oncogenesis and Alteration of Immunity

Mariam Shallak

Greta Forlani

Roberto S Accolla

2021

CIITA-transduced glioblastoma cells uncover a rich repertoire of clinically relevant tumor-associated HLA-II antigens

Molecular & Cellular Proteomics

Greta Forlani

Justine Michaux

HuiSong Pak

Florian Huber

Elodie Lauret Marie Joseph

...

2021/1/1

Dual cytoplasmic and nuclear localization of HTLV-1-encoded HBZ protein is a unique feature of adult T-cell leukemia

Haematologica

Greta Forlani

Mariam Shallak

Alessandra Tedeschi

Ilaria Cavallari

Ambroise Marçais

...

2021/8/8

Abstract LB-094: Hepavac-101 first-in-man clinical trial of a multi-peptide-based vaccine for hepatocellular carcinoma

Cancer Research

Luigi Buonaguro

Andrea Mayer

Markus Loeffler

Sarah Missel

Roberto Accolla

...

2020/8/15

Novel strategies for anti-tumor vaccines

Frontiers in immunology

Roberto S Accolla

Luigi Buonaguro

Cornelis Melief

Hans-George Rammensee

Michal Bassani-Sternberg

2020/1/17

Epigenetic silencing of HTLV-1 expression by the HBZ RNA through interference with the basal transcription machinery

Blood advances

Hélène Gazon

Pradeep Singh Chauhan

Florent Porquet

Gabriela Brunsting Hoffmann

Roberto Accolla

...

2020/11/10

See List of Professors in Roberto S. Accolla University(Università degli Studi dell'Insubria)